A detailed history of Mengis Capital Management, Inc. transactions in Silk Road Medical Inc stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 10,225 shares of SILK stock, worth $281,085. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,225
Previous 10,225 -0.0%
Holding current value
$281,085
Previous $276,000 -0.0%
% of portfolio
0.06%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$11.38 - $19.03 $1,422 - $2,378
-125 Reduced 1.21%
10,225 $187,000
Q4 2023

Feb 01, 2024

SELL
$6.29 - $15.72 $17,234 - $43,072
-2,740 Reduced 20.93%
10,350 $126,000
Q3 2023

Nov 09, 2023

SELL
$14.99 - $32.65 $4,497 - $9,795
-300 Reduced 2.24%
13,090 $196,000
Q2 2023

Aug 08, 2023

BUY
$29.76 - $46.14 $17,260 - $26,761
580 Added 4.53%
13,390 $435,000
Q1 2023

May 05, 2023

BUY
$38.09 - $57.79 $487,932 - $740,289
12,810 New
12,810 $501,000
Q2 2022

Jul 19, 2022

BUY
$28.03 - $45.8 $17,518 - $28,625
625 Added 5.28%
12,460 $453,000
Q1 2022

May 02, 2022

SELL
$29.24 - $44.06 $7,310 - $11,015
-250 Reduced 2.07%
11,835 $488,000
Q3 2021

Nov 03, 2021

SELL
$44.0 - $65.8 $4,400 - $6,580
-100 Reduced 0.82%
12,085 $665,000
Q1 2021

May 07, 2021

SELL
$46.31 - $62.7 $11,577 - $15,675
-250 Reduced 2.01%
12,185 $617,000
Q4 2020

Feb 03, 2021

BUY
$55.51 - $69.94 $102,693 - $129,389
1,850 Added 17.48%
12,435 $783,000
Q3 2020

Oct 29, 2020

SELL
$42.19 - $69.61 $4,219 - $6,961
-100 Reduced 0.94%
10,585 $711,000
Q2 2020

Jul 22, 2020

BUY
$27.55 - $43.28 $8,265 - $12,984
300 Added 2.89%
10,685 $447,000
Q1 2020

May 06, 2020

BUY
$23.16 - $47.8 $8,106 - $16,730
350 Added 3.49%
10,385 $326,000
Q4 2019

Feb 06, 2020

BUY
$27.97 - $40.38 $280,678 - $405,213
10,035 New
10,035 $405,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Mengis Capital Management, Inc. Portfolio

Follow Mengis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.